{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:05:47Z","timestamp":1791209147184,"version":"4.1.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"12-13","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/17576180.2026.2732419","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:32:21Z","timestamp":1789277541000},"page":"1117-1129","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["From ADA positivity to clinical decision: a context-of-use framework for reflex testing, sampling frequency and stopping rules in immunogenicity assessment"],"prefix":"10.1080","volume":"18","author":[{"given":"Ahmad Z.","family":"Al Meslamani","sequence":"first","affiliation":[{"name":"Al Ain University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan S.","family":"Jarab","sequence":"additional","affiliation":[{"name":"Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"El Sharu","sequence":"additional","affiliation":[{"name":"Case Western Reserve University","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeijah Ahmed","family":"Al Marshoodi","sequence":"additional","affiliation":[{"name":"University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Elrefae","sequence":"additional","affiliation":[{"name":"Northwick Park Hospital","place":["Harrow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Esmaeel","family":"Kataf","sequence":"additional","affiliation":[{"name":"Damascus University","place":["Damascus, Syria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9599-2"},{"key":"e_1_3_6_4_1","unstructured":"US FDA. Immunogenicity testing of therapeutic protein products \u2014 developing and validating assays for anti-drug antibody detection [internet]. 2019 [cited 2025 Nov 11]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/immunogenicity-testing-therapeutic-protein-products-developing-and-validating-assays-anti-drug"},{"key":"e_1_3_6_5_1","unstructured":"European Medicines Agency (EMA). Guideline on immunogenicity assessment of therapeutic proteins [internet]. 2017 [cited 2024 Apr 12]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-immunogenicity-assessment-therapeutic-proteins-revision-1_en.pdf"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1401178"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00649-y"},{"key":"e_1_3_6_8_1","unstructured":"FDA. Immunogenicity testing of therapeutic protein products \u2014 developing and validating assays for anti-drug antibody detection. Final. 2019."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-01051-x"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581153"},{"key":"e_1_3_6_12_1","unstructured":"US FDA. Submitting clinical trial datasets to evaluate the impact of immunogenicity on the pharmacokinetics of a drug [internet]. 2026 [cited 2026 Jul 28]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/submitting-clinical-trial-datasets-evaluate-impact-immunogenicity-pharmacokinetics-drug"},{"key":"e_1_3_6_13_1","unstructured":"US FDA. M15 General principles for model-informed Drug development [internet]. 2026 [cited 2026 Jul 28]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/m15-general-principles-model-informed-drug-development"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01186-8"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.05.008"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.103870"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1cb00067e"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-0420-0"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00930-w"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13230"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.007"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2026.2667854"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00830-5"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9878-1"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-017-0153-x"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-022-00762-6"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01365"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu297"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.70019"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00044-X"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16733"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12176"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103016"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074943"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14131403"},{"key":"e_1_3_6_36_1","unstructured":"US FDA. ERBITUX (cetuximab) prescribing information [Internet]. 2009 [cited 2026 Jul 30]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/125084s168lbl.pdf"},{"key":"e_1_3_6_37_1","volume-title":"Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins","author":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP)","year":"2007","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins. London, UK; 2007."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-022-00712-2"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01165-z"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaf149"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.04.058"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00954-2"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead690"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otab048"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175207"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12652"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2015.01.003"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2026.2623034"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-021-00507-5"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1732"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00993-9"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1694"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2026.2641928"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2025.2487377"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00955-1"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1466372"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01118-6"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.05.010"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00389-8"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.112688"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00856-9"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438251"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-017-0148-7"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.041"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-01003-8"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.123"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.970165"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2732419","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17576180.2026.2732419","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2732419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:19:29Z","timestamp":1791206369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2026.2732419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":65,"journal-issue":{"issue":"12-13","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/17576180.2026.2732419"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2026.2732419","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}